ABSTRACT Background/Aims To compare homocysteine (Hcy) concentration in the blood plasma, vitreous and aqueous of eyes with proliferative diabetic retinopathy (PDR) against control, and to investigate associations between Hcy concentration in blood plasma with that of aqueous and vitreous in these two groups. Methods Blood plasma, aqueous and vitreous samples were collected during combined cataract and pars plana vitrectomy from 20 eyes with PDR and 21 eyes of patients without diabetes mellitus. Hcy concentration in the samples was determined by chemiluminescent microparticle immunoassay.
INTRODUCTION
Diabetic retinopathy is one of the microvascular complications of diabetes mellitus and is the leading cause of blindness in adults of working age. 1 Its pathogenesis involves hyperglycaemia as the main driving force, causing retinal capillary damage through several mechanisms. 2 This capillary damage leads to progressive retinal hypoxia which in turn activates a plethora of angiogenic growth factors and eventually causes characteristic retinal neovascularisation.
Homocysteine (Hcy) is a sulphur-containing amino acid which is formed during the intracellular demethylation of methionine, an essential amino acid derived from dietary protein. In normal subjects, total Hcy level differs among individuals and depends on various factors such as gender, age, renal function, genetic factors, dietary intake of folate, vitamin B 6 and vitamin B 12 .
3 Elevated plasma Hcy level in normal subjects has been shown to be an independent risk factor for cardiovascular diseases. 4e7 In addition, homocystenuria patients who have severely elevated Hcy levels in blood plasma are found to have high risk of early arteriosclerosis and thromboembolism. 8 Similarly, Hcy may play a role in the pathogenesis of diabetic retinopathy. Several studies have shown association between blood plasma Hcy level and the prevalence of diabetic retinopathy.
9e12
Studies that measure Hcy levels in ocular fluids of eyes with diabetic retinopathy are limited. To our knowledge, only two such studies have been made in the vitreous humour. 13 14 In our study, we wish to compare Hcy levels in the blood plasma, vitreous and aqueous of eyes between two patient groups: those with proliferative diabetic retinopathy (PDR) and those without (control). We are also interested in investigating patterns of association between Hcy levels in the blood plasma and the two ocular fluids in these two groups of patients.
MATERIALS AND METHODS
The present case-control study adhered to the Declaration of Helsinki and Good Clinical Practice guidelines. Institutional Review Board approval was obtained by the Medical Ethics Board of the University of Malaya Medical Centre (Reference number: 756.6). This work was supported by University of Malaya Research Grant (Grant number: UMRG/RG180/10HTM). Patients were recruited from the eye department of University of Malaya Medical Centre, Kuala Lumpur, Malaysia from June 2010 to October 2010. Patients undergoing combined cataract surgery with pars plana vitrectomy were first screened for suitability to be included in this study. They then underwent slit lamp examination, gonioscopy to rule out angle neovascularisation and dilated fundus examination to assess the vitreoretinal pathologies. For each eligible patient, informed consent to participate in this study was obtained. The treatment group consisted of 20 patients who had type 2 diabetes mellitus and underwent combined cataract extraction and pars plana vitrectomy for tractional retinal detachment due to PDR. In the control group, there were 21 non-diabetic patients who underwent combined cataract extraction and pars plana vitrectomy for other indicated eye conditions. Since certain medical conditions are known to affect Hcy level, we excluded patients who had the following conditions from the study: fresh vitreous haemorrhage, any inflammatory eye condition, rubeosis iridis, plasma creatinine level above 450 mmol/l, pregnancy and patients who were on methotrexate or any antiepileptic medication.
Aqueous and vitreous collection
At the beginning of the combined cataract extraction and pars plana vitrectomy surgeries, samples of undiluted aqueous humour (at least 0.1 ml) were manually aspirated into disposable tuberculin syringes. Undiluted vitreous samples (at least 0.3 ml) were aspirated from the central vitreous cavity 20 gauge vitreous cutter into a 1 ml syringe, before the infusion of balanced salt solution. Fasting blood samples were collected by venous puncture on the day of surgery. The samples were transported in ice to the laboratory immediately after collection, and then promptly centrifuged at 5000 rpm for 10 min. They were then aliquoted and stored at À208C until ready for assaying. 15 
Measurement of Hcy levels
The Hcy levels in the samples were analysed using commercially available chemiluminescent microparticle immunoassay test kits (ARCHITECT Homocysteine Reagent Kits, Abbott Diagnostics Division, Abbott Park, Illinois, USA). All tests conducted adhered to the quality control procedures as recommended by the manufacturer 's operation manual. The Hcy assay is designed to have an assay precision of 10% or less total coefficient of variation as quoted by the manufacturer.
Statistical analysis
Relative Hcy levels in the blood plasma, vitreous and aqueous between the PDR and control groups were compared using the ratio of the geometric mean (GMR) of Hcy concentration. Since the quantileequantile plot showed that the distribution of the log (base e) of Hcy concentration in the three variables were approximately normal, we computed the 95% CI of the GMR as follows: 16 the 95% CI of the difference in mean log of Hcy concentration was first computed, followed by exponentiation of its left and right hand limits. For investigating association, we used the Pearson correlation coefficient (r). As there were two comparisons of interest (blood plasmaeaqueous; blood plasmaevitreous), we applied Bonferroni correction to the usual 5% significance level. This means that each test had to have p value of less than 2.5% before it could be considered statistically significant. All statistical analyses were done using R version 2.9.2. 17 
RESULTS

Characteristics of patient groups
The mean age of patients in the PDR group (n¼20) was 57 years (SD 11 years; median 56 years; range 34e75 years). There were eight female and 12 male subjects. The medical history of most patients was complexdpatients often had one or more of the following conditions: hypertension (15), hypercholesterolaemia (2), ischaemic heart disease (5), renal impairment (2) and a history of stroke (2). The mean and median self-reported duration of diabetes mellitus status were about 10 years (SD 4 years; range 5e20 years). For patients in the control group (n¼21), the mean age was 61 years (SD 9 years; median 62 years; range 35e71 years). There were eight female and 13 male patients. Ocular diagnoses included 10 epiretinal membrane, eight macular hole, and three rhegmatogenous retinal detachment cases. More than half of the patients (12) had no medical history. Of the remainder, there were seven patients with hypertension, three with hypercholesterolaemia, one with ischaemic heart disease and one with bronchial asthma. Table 1 shows the estimated mean Hcy concentration in the blood plasma, vitreous and aqueous in the treatment and control groups, together with their differences. Similar estimates of the mean of the log of Hcy concentration are given in table 2. The distribution of the log of Hcy concentration in the various fluids is given in figure 1 . The estimated GMR of the PDR against the control group is 1.31 for the blood plasma (95% CI 1.20 to 1.43), 1.33 for the vitreous (95% CI 1.22 to 1.46) and 1.30 for the aqueous (95% CI 1.18 to 1.42). This result indicates that the GMR of Hcy concentration is approximately elevated by 30% in the blood plasma, vitreous and aqueous of patients who suffer from PDR, compared with those in the control group. Since the lower limit of the 95% CI of GMR is at least 1.18, the current findings are biologically significant. Figure 2 shows pairwise scatterplots of the log of Hcy concentration in the blood plasma, vitreous and aqueous of patients in the control and PDR groups. The log of Hcy concentration in the aqueous humour and blood plasma of PDR patients are significantly associated (r¼0.68; p value <0.001), and similarly so between the blood plasma and vitreous humour (r¼0.71; p value <0.001). For the control group, the log of Hcy concentration in the aqueous humour is not significantly associated with those in the blood plasma (r¼0.24; p value ¼0.30). However, those between the blood plasma and vitreous humour are significantly associated (r¼0.66; p value ¼0.001).
DISCUSSION
The pathogenesis of diabetic retinopathy involves several mechanisms of retinal capillary damage, including increased polyol pathway, activation of protein kinase C, increased nonenzymatic glycation and generation of reactive oxygen species. 2 Moreover, Hcy may play a role in these vascular injuries. Several studies have shown that elevated plasma Hcy level is associated with a higher prevalence of diabetic retinopathy. In the present study, consideration of the GMR of Hcy concentration in the PDR group against the control has yielded an interesting finding: the GMR of Hcy concentration is almost The estimated difference is given in the form of mean difference 61 SE. Hcy, homocysteine; PDR, proliferative diabetic retinopathy. The difference is given in the form of mean difference 61 SE. Hcy, homocysteine; PDR, proliferative diabetic retinopathy.
uniformly 30% higher in the PDR group compared with the control. This result agrees with previous studies that reported higher Hcy level in blood plasma 9e12 and vitreous 13 14 in the PDR group. The exact mechanism by which Hcy causes vascular damage is unknown but various laboratory investigations have suggested several possible pathways. These include impairment of endothelial function, 18 19 peroxidation of low density lipids, 20 increased monocyte and T cell adhesion to the vessel wall, 21 activation of the inflammatory pathway, stimulatory effects on the smooth-muscle proliferation, 22 and the thrombotic tendency mediated by activation of the coagulation factors and platelet dysfunction. 23 Indeed, Hcy is found to have stimulatory effect on the expression of vascular endothelial growth factor (VEGF) by the retinal glial cells in vitro. 24 25 The VEGF is a potent angiogenic factor involved in neovascularisation in PDR. 26 27 A recent study by Roybal et al showed that Hcy increases the expression of VEGF in retinal pigmented epithelium cell line. 25 An animal study also found that short term hyperhomocysteinaemia increased VEGF immunoreactivity in the retina of rats.
24 Therefore, an elevated Hcy level in the vitreous might be important in the pathogenesis of PDR.
The significant association between Hcy levels in the blood plasma and vitreous of patients with PDR may indicate a breakdown of the blooderetinal barrier, thus augmenting the diffusion of plasma Hcy into the vitreous. Alternatively, it is also possible that Hcy mediates a change in the vascular permeability of the retinal vessels. 28 On the other hand, significant association detected between the Hcy levels of blood plasma and vitreous in the control group contradicts the results of a previous study, 14 which found no association between these levels in their controls. This disagreement might be due to differences in the characteristics of patients in the control group; our control group consisted 14% of patients with rhegmatogenous retinal detachment (n¼3) and 86% with macular pathologies (epiretinal membrane and macular hole) whereas their study consisted of 50% of patients with retinal detachment (n¼6) and 50% with nucleus drop. Studies have shown that a certain degree of impairment of the blooderetinal barrier may be present in retinal detachment. 29 30 Furthermore, Coral et al found that vitreous Hcy level was elevated in rhegmatogenous retinal detachment and attributed it to the breakdown of outer blooderetinal barrier. 13 The fact that significant association between the plasma and aqueous level was detected only in the PDR group but not in the control group requires an explanation. There are evidences implicating the breakdown of the bloodeaqueous barrier in eyes with PDR. Moriarty et al found that flare, an indirect indicator of the bloodeaqueous integrity, was greater in PDR compared with the other stages of diabetic retinopathy. 31 Furthermore, a study using iris fluorescein angiography showed that peripupillary dye leakage caused by increased capillary permeability was commonly found among diabetic patients. There appears to be some correlation between the extent of retinal ischaemia and severity of diabetic iridopathy; hence, more marked dye leakage is seen in patients with PDR. 32 Bleich et al found significantly higher levels of Hcy levels in the aqueous of patients with pseudoexfoliative glaucoma compared with controls, which they also attributed to the breakdown of bloodeaqueous barrier. 33 Thus, we hypothesise that in eyes with PDR, the breakdown of bloodeaqueous barrier enhances the diffusion of plasma Hcy into the aqueous while those in the control group have a functional bloodeaqueous barrier that regulates its aqueous Hcy concentration.
In conclusion, our study shows that the GMR of Hcy concentration in the plasma, vitreous and aqueous is approximately 30% higher in the PDR group compared with the control. There is significant association of Hcy levels between the plasma and vitreous in both the PDR and control groups. However, significant association between the Hcy levels of plasma and aqueous was only seen in patients in the PDR group, and not in the control group.
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